Cargando…

Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behçet's Disease

PURPOSE: We aimed to determine the prevalence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in a large group of Korean patients with Behçet's disease (BD), with and without joint involvement, and to compare these findings with the prevalences of anti-CCP antibodies in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Sung Bin, Lee, Ju Hee, Ahn, Keun Jae, Bae, Byung Gi, Kim, Taegyun, Park, Yong-Beom, Lee, Soo-Kon, Lee, Kwang Hoon, Bang, Dongsik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381466/ https://www.ncbi.nlm.nih.gov/pubmed/22665343 http://dx.doi.org/10.3349/ymj.2012.53.4.759

Ejemplares similares

Behçet's Disease Combined with Various Types of Fistula
por: Chung, Hye Jin, et al.
Publicado: (2005)

Expression of Pro-inflammatory Protein S100A12 (EN-RAGE) in Behçet's Disease and Its Association with Disease Activity: A Pilot Study
por: Han, Eun Chun, et al.
Publicado: (2011)

Carpal Tunnel Syndrome in Behçet's Disease
por: Lee, Jungsoo, et al.
Publicado: (2015)

Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role
por: Kim, Youngkyun, et al.
Publicado: (2015)

Immunopathogenic Role of Herpes Simplex Virus in Behçet's Disease
por: Kim, Do Young, et al.
Publicado: (2013)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment
por: Elkayam, Ori, et al.
Publicado: (2010)

New Insights in the Clinical Understanding of Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2012)

Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis
por: Abdel Fattah, Nermeen SA, et al.
Publicado: (2009)

Immune Reactions in Behçet's Disease
por: Kaneko, Fumio, et al.
Publicado: (2014)

Association of TNFA Promoter Region Haplotype in Behçet's Disease
por: Park, KyungSook, et al.
Publicado: (2006)

The Behçet's Disease Quality of Life: Reliability and Validity of the Korean Version
por: Yi, Sang Won, et al.
Publicado: (2008)

Two Cases of Acute Leukopenia Induced by Colchicine with Concurrent Immunosuppressants Use in Behçet's Disease
por: Lee, Kyu-Yeop, et al.
Publicado: (2008)

Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families
por: Kim, Seong-Kyu, et al.
Publicado: (2013)

Enhancement of Th1/Th17 inflammation by TRIM21 in Behçet’s disease
por: Ahn, Yuri, et al.
Publicado: (2017)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
por: Hamooda, Mohamed, et al.
Publicado: (2016)

Correlation of Anti-Cyclic Citrullinated Antibody with Hand Joint Erosion Score in Rheumatoid Arthritis Patients
por: Kim, Hyun Hee, et al.
Publicado: (2010)

A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and interstitial lung disease in systemic sclerosis
por: Ha, Jang Woo, et al.
Publicado: (2022)

Renal Manifestations in 2007 Korean Patients with Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2013)

Mucocutaneous manifestations of Behçet’s disease: Pathogenesis and management from perspectives of vasculitis
por: Kim, Doyoung, et al.
Publicado: (2022)

Influence of sex on patients with Behçet's disease in Korea.
por: Bang, Dong Sik, et al.
Publicado: (2003)

Insights to Clinical Use of Serial Determination in Titers of Cyclic Citrullinated Peptide Autoantibodies
por: Kogure, Toshiaki, et al.
Publicado: (2007)

Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis
por: Tebo, Anne E, et al.
Publicado: (2012)

Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis
por: El-Banna, Hassan, et al.
Publicado: (2014)

Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies
por: Vignesh, Ammapati Paul Pandian, et al.
Publicado: (2015)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

Anti–Cyclic Citrullinated Peptide Antibody as a Predictor of Rheumathoid Arthritis Complications
por: Mekic, Mevludin, et al.
Publicado: (2020)

Salivary anti-cyclic citrullinated peptide as a screening tool for rheumatoid arthritis
por: Mortazavi, Nazanin, et al.
Publicado: (2022)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Study on the evaluation of rheumatoid arthritis via doppler ultrasonography and anti-cyclic citrullinated peptide antibody analysis
por: Shang, Li-na, et al.
Publicado: (2020)

Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study
por: Bang, So-Young, et al.
Publicado: (2010)

Intraindividual Changes in Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody Tests in Korean Patients Visiting Local Clinics and Hospitals
por: Choi, Rihwa, et al.
Publicado: (2022)

Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
por: Ahn, Sung Soo, et al.
Publicado: (2022)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
por: Alexiou, Ioannis, et al.
Publicado: (2007)

Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
por: De Rooy, Diederik PC, et al.
Publicado: (2011)

Clinical significance of anti-cyclic citrullinated peptide antibodies in patients with juvenile rheumatoid arthritis
por: Bo, Li, et al.
Publicado: (2008)

Anti-keratin and anti-cyclic citrullinated peptide autoantibodies in patients with juvenile idiopathic arthritis
por: Vavrinec, J, et al.
Publicado: (2002)

The influence of anti-cyclic citrullinated peptide on anticentromere antibody-positive rheumatoid arthritis patients
por: Jearn, La-He, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vetesrkn6p09etr5gf76069q05